Skip to main content
OpenTrials
Completed

NCT Number: NCT00371774

Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program

Purpose:

To develop a real time national clinical database to support and share best practices,

1. To generate hypotheses for future clinical research 2. To understand how AMEVIVE is used in routine clinical practice/real world setting.

Each patient visit will include the following observational endpoints:

1. AMEVIVE dosing 2. Number of courses 3. Concomitant treatment 4. Response to treatment (patient and physician global assessments) 5. Status of other psoriasis-related medical conditions 6. Time to re-treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Plaque Psoriasis Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Calgary, Alberta, Canada

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Amevive is clinically indicated for the patient

Exclusion criteria

  • Amevive is contraindicated for the patient

Treatment and study plan

Primary outcomes

  1. Understand how AMEVIVE is used in routine clinical practice/real world setting

    Time frame: End of study

Sponsors and collaborators

Lead sponsor

Astellas Pharma Inc

Industry

Registry information

Important dates

Study start
2005
Primary completion
2008
Study completion
2008
First posted
Sep 4, 2006
Registry last updated
Nov 17, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.